Martha Morehouse Medical plaza
Columbus, Ohio 43221
0 studies enrolling now · 16 studies all time
What they study most
Advanced Cancer, Bacterial Infections, Diabetes Mellitus, Diabetic Foot Ulcer, Foot Ulcer, Genes, BRCA 1, Hemiparesis, Infected Ulcer of Skin, Intracerebral Hemorrhage, Locally Advanced or Metastatic Solid Tumors, Medical Imaging Data, Myasthenia Gravis, Ocular
Studies at this site
- A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis — Running, not enrolling
- A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer — Running, not enrolling
- Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE) — Completed
- An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer — Completed
- Early Parkinson's Disease Monotherapy With CVN424 — Completed
- miR-200b & miR-21 in Diabetic Wounds — Completed
- Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing — Stopped early
- Comprehensive Imaging of Perforator Vessels and Subcutaneous Vascular Network With No-Exogenous Contrast and Non-Ionizing-Radiation Magnetic Resonance Angiography — Status unconfirmed
- Online Surveys to Assess the Perception and Performance of Imaging and Associated Aspects — Withdrawn before enrolling
- Feasibility Assessment of Next-generation PET Technology and Procedures — Status unconfirmed
- The Wright Center of Innovation Imaging Archive — Running, not enrolling
- Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors — Stopped early
- A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer — Completed
- Nutritional Regulation of Wound Inflammation: Part III — Completed
- Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage — Stopped early
- Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients — Completed